• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CAPIOX FX15 OXY WEST WITH 4L RES STERILE; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CAPIOX FX15 OXY WEST WITH 4L RES STERILE; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*FX15RW40C
Medical Device Problem Code Pressure Problem (3012)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/09/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Terumo has received the device for evaluation; however, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references evaluation conclusion code 11.  h3: 81 - evaluation is in progress, but not yet concluded.
 
Event or Problem Description
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass there was a severe pressure excursion on the oxygenator.There was a 15 minute - minute delay to open, prime and activate another oxygenator.No consequence or impact to patient *product was changed out *procedure was completed successfully.
 
Additional Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on may 06, 2024.Upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - added exp date).G3 (date received by manufacturer).G6 (indication that this is a follow-up report).H2 (follow-up due to additional information and device evaluation).H3 (updated device evaluated by manufacturer).H4 (device manufacture date).H6 (identification of evaluation codes 10, 3331, 213, 67).The returned sample was inspected upon receipt to show no visual anomalies with the device.After rinsing the sample, it was tested for the pressure drop with bovine blood.The maximum blood flow rate of 5l/min was able to be achieved.Saline solution was flowed through the blood channel, no blood clots were noted.As the event could not be replicated in laboratory conditions, a definitive root cause could not be determined.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX15 OXY WEST WITH 4L RES STERILE
Common Device Name
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
Manufacturer (Section G)
SAME
Manufacturer Contact
douglas patton
125 blue ball road
elkton, MD 21921
7346634145
MDR Report Key18850146
Report Number1124841-2024-00036
Device Sequence Number7532564
Product Code DTZ
UDI-Device Identifier00699753450790
UDI-Public(01)00699753450790
Combination Product (Y/N)N
Initial Reporter StateMO
Initial Reporter CountryUS
PMA/510(K) Number
K153213
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/14/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number3CX*FX15RW40C
Device Catalogue NumberN/A
Device Lot Number3P18
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/28/2024
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/12/2024
Supplement Date Received by Manufacturer04/29/2024
Initial Report FDA Received Date03/06/2024
Supplement Report FDA Received Date05/14/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/21/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-